Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 8/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.62 |
| ▸ | CASP1 | P29466 | 2/20 | 0.62 |
| ▸ | CASP7 | P55210 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | ACHE | P22303 | 4/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10336303 | 0.81 | HTT (0.48) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL4580168 | 0.81 | MCL1 (0.55) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL8897227 | 0.81 | MAOA (0.50) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL3467047 | 0.79 | CYP3A4 (0.59) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL30018039 | 0.78 | MCL1 (0.47) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL3447032 | 0.77 | MAOA (0.47) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| SCHEMBL7754898 | 0.77 | HTT (0.53) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| Pachyrrizine SCHEMBL12062103 | 0.77 | CYP3A4 (1.00) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| Pachyrrizine SCHEMBL31474215 | 0.77 | CYP3A4 (1.00) | CYP3A4HSD17B10CASP1CASP7KDM4E | |
| Pachyrrizine SCHEMBL29350520 | 0.77 | CYP3A4 (1.00) | CYP3A4HSD17B10CASP1CASP7KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230050070-A1 | Antimicrobial Composition | ATLANTIC TECHNOLOGIECAL UNIV (IE) | 2023-02-16 | — | — | US | claimed |
| WO-2017115382-A1 | CUSTOMIZED TOPICAL COMPOSITION | BANERJI SANJAY (IN) | 2017-07-06 | — | — | WO | claimed |
| US-20160235708-A1 | TOPICAL PIGMENTORY COMPOSITION | BANERJI SANJAY (IN) | 2016-08-18 | — | — | US | claimed |
| WO-2015049694-A9 | TOPICAL PIGMENTORY COMPOSITION | BANERJI SANJAY (IN) | 2016-02-04 | — | — | WO | claimed |
| WO-2015049694-A1 | TOPICAL PIGMENTORY COMPOSITION | BANERJI SANJAY (IN) | 2015-04-09 | — | — | WO | claimed |
| EP-1309333-B1 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | CONTROL OX OY (FI) | 2009-09-02 | — | — | EP | claimed |
| US-20040058983-A1 | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections | CONTROL-OX OY (FI) | 2004-03-25 | — | — | US | claimed |
| JP-2004506656-A | — | — | 2004-03-04 | — | — | JP | claimed |
| EP-1309333-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | Control-Ox OY (FI) | 2003-05-14 | — | — | EP | claimed |
| WO-2002014464-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | CONTROL-OX OY (FI) | 2002-02-21 | — | — | WO | claimed |
| US-20240226170-A9 | USE OF MBV FOR TREATING AUTOIMMUNE DISEASE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131075-A1 | USE OF MBV FOR TREATING AUTOIMMUNE DISEASE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-04-25 | — | — | US | disclosed |
| US-20230050070-A1 | Antimicrobial Composition | ATLANTIC TECHNOLOGIECAL UNIV (IE) | 2023-02-16 | — | — | US | disclosed |
| US-20230022880-A1 | Antimicrobial Composition | INSTITUTE OF TECH SLIGO (IE) | 2023-01-26 | — | — | US | disclosed |
| EP-4054606-A1 | USE OF MBV FOR TREATING AUTOIMMUNE DISEAE | University of Pittsburgh - of the Commonwealth System of Higher Education (US) | 2022-09-14 | — | — | EP | disclosed |
| EP-0453497-A1 | TREATMENT METHODS AND VACCINES | BISACCIA, Emil (US) | 1991-10-30 | — | — | EP | disclosed |
| WO-1990007952-A1 | TREATMENT METHODS AND VACCINES | BISACCIA EMIL (US) | 1990-07-26 | — | — | WO | disclosed |
| EP-0337866-A2 | 5-Methoxypsoralene against depression | Goupil, Jean-Jacques (FR) | 1989-10-18 | — | — | EP | disclosed |
| EP-0316016-A2 | Modified oligonucleotides | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1989-05-17 | — | — | EP | disclosed |
| EP-0001733-A1 | 5-Methoxy-psoralene as a new medicament and process for the synthesis | Goupil, Jean-Jacques (FR) | 1979-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058983-A1 | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections | PPARG, QPCT, PGC | CYP3A4 1053/4885HSD17B10 1291/4885CASP1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.